Loading...

Abano Healthcare Group

NZSE:ABA
Snowflake Description

6 star dividend payer and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ABA
NZSE
NZ$106M
Market Cap
  1. Home
  2. NZ
  3. Healthcare
Company description

Abano Healthcare Group Limited provides healthcare and medical services. The last earnings update was 119 days ago. More info.


Add to Portfolio Compare Print
  • Abano Healthcare Group has significant price volatility in the past 3 months.
ABA Share Price and Events
7 Day Returns
-1.7%
NZSE:ABA
3.7%
NZ Healthcare
2.2%
NZ Market
1 Year Returns
-53.5%
NZSE:ABA
4.7%
NZ Healthcare
11.7%
NZ Market
ABA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Abano Healthcare Group (ABA) -1.7% -30.5% -38.2% -53.5% -47.7% -38%
NZ Healthcare 3.7% -0.1% 1.3% 4.7% 26.7% 61%
NZ Market 2.2% 3.9% 7% 11.7% 23.8% 48.8%
1 Year Return vs Industry and Market
  • ABA underperformed the Healthcare industry which returned 4.7% over the past year.
  • ABA underperformed the Market in New Zealand which returned 11.7% over the past year.
Price Volatility
ABA
Industry
5yr Volatility vs Market

Value

 Is Abano Healthcare Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Abano Healthcare Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Abano Healthcare Group.

NZSE:ABA Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 2 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.9%
Perpetual Growth Rate 10-Year NZ Government Bond Rate 2.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NZSE:ABA
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year NZ Govt Bond Rate 2.4%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.72
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.715 (1 + (1- 28%) (132.57%))
1.267
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.27
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.37% + (1.267 * 5.96%)
9.92%

Discounted Cash Flow Calculation for NZSE:ABA using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Abano Healthcare Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NZSE:ABA DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (NZD, Millions) Source Present Value
Discounted (@ 9.92%)
2019 9.47 Est @ -9.9% 8.61
2020 8.88 Est @ -6.22% 7.35
2021 8.55 Est @ -3.64% 6.44
2022 8.40 Est @ -1.84% 5.75
2023 8.35 Est @ -0.58% 5.20
2024 8.37 Est @ 0.31% 4.75
2025 8.45 Est @ 0.93% 4.36
2026 8.56 Est @ 1.36% 4.02
2027 8.71 Est @ 1.66% 3.72
2028 8.87 Est @ 1.87% 3.45
Present value of next 10 years cash flows NZ$53.64
NZSE:ABA DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= NZ$8.87 × (1 + 2.37%) ÷ (9.92% – 2.37%)
NZ$120.28
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= NZ$120.28 ÷ (1 + 9.92%)10
NZ$46.71
NZSE:ABA Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= NZ$53.64 + NZ$46.71
NZ$100.35
Equity Value per Share
(NZD)
= Total value / Shares Outstanding
= NZ$100.35 / 26.14
NZ$3.84
NZSE:ABA Discount to Share Price
Calculation Result
Value per share (NZD) From above. NZ$3.84
Current discount Discount to share price of NZ$4.03
= -1 x (NZ$4.03 - NZ$3.84) / NZ$3.84
-5%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Abano Healthcare Group is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Abano Healthcare Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Abano Healthcare Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NZSE:ABA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-11-30) in NZD NZ$0.40
NZSE:ABA Share Price ** NZSE (2019-04-18) in NZD NZ$4.03
New Zealand Healthcare Industry PE Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 11.12x
New Zealand Market PE Ratio Median Figure of 90 Publicly-Listed Companies 17.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Abano Healthcare Group.

NZSE:ABA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NZSE:ABA Share Price ÷ EPS (both in NZD)

= 4.03 ÷ 0.40

9.97x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Abano Healthcare Group is good value based on earnings compared to the NZ Healthcare industry average.
  • Abano Healthcare Group is good value based on earnings compared to the New Zealand market.
Price based on expected Growth
Does Abano Healthcare Group's expected growth come at a high price?
Raw Data
NZSE:ABA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 9.97x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
12.1%per year
New Zealand Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 0.99x
New Zealand Market PEG Ratio Median Figure of 66 Publicly-Listed Companies 1.44x

*Line of best fit is calculated by linear regression .

NZSE:ABA PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 9.97x ÷ 12.1%

0.82x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Abano Healthcare Group is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Abano Healthcare Group's assets?
Raw Data
NZSE:ABA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-11-30) in NZD NZ$6.15
NZSE:ABA Share Price * NZSE (2019-04-18) in NZD NZ$4.03
New Zealand Healthcare Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.17x
New Zealand Market PB Ratio Median Figure of 126 Publicly-Listed Companies 1.53x
NZSE:ABA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NZSE:ABA Share Price ÷ Book Value per Share (both in NZD)

= 4.03 ÷ 6.15

0.66x

* Primary Listing of Abano Healthcare Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Abano Healthcare Group is good value based on assets compared to the NZ Healthcare industry average.
X
Value checks
We assess Abano Healthcare Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Abano Healthcare Group has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Abano Healthcare Group expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Abano Healthcare Group expected to grow at an attractive rate?
  • Abano Healthcare Group's earnings growth is expected to exceed the low risk savings rate of 2.4%.
Growth vs Market Checks
  • Abano Healthcare Group's earnings growth is expected to exceed the New Zealand market average.
  • Abano Healthcare Group's revenue growth is positive but not above the New Zealand market average.
Annual Growth Rates Comparison
Raw Data
NZSE:ABA Future Growth Rates Data Sources
Data Point Source Value (per year)
NZSE:ABA Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 12.1%
NZSE:ABA Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 3.2%
New Zealand Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 9.7%
New Zealand Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 10.2%
New Zealand Market Earnings Growth Rate Market Cap Weighted Average 6.1%
New Zealand Market Revenue Growth Rate Market Cap Weighted Average 5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NZSE:ABA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in NZD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NZSE:ABA Future Estimates Data
Date (Data in NZD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-05-31 298 16 1
2021-05-31 292 13 2
2020-05-31 282 12 2
2019-05-31 271 11 2
NZSE:ABA Past Financials Data
Date (Data in NZD Millions) Revenue Cash Flow Net Income *
2018-11-30 269 27 10
2018-08-31 259 28 10
2018-05-31 250 30 10
2017-11-30 224 26 10
2017-08-31 221 24 10
2017-05-31 217 22 11
2017-02-28 228 22 21
2016-11-30 223 21 31
2016-08-31 218 21 30
2016-05-31 214 20 28
2016-02-29 207 21 17

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Abano Healthcare Group's earnings are expected to grow by 12.1% yearly, however this is not considered high growth (20% yearly).
  • Abano Healthcare Group's revenue is expected to grow by 3.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NZSE:ABA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Abano Healthcare Group Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NZSE:ABA Future Estimates Data
Date (Data in NZD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-05-31 0.58 0.58 0.58 1.00
2021-05-31 0.50 0.54 0.47 2.00
2020-05-31 0.46 0.51 0.42 2.00
2019-05-31 0.41 0.46 0.36 2.00
NZSE:ABA Past Financials Data
Date (Data in NZD Millions) EPS *
2018-11-30 0.40
2018-08-31 0.41
2018-05-31 0.42
2017-11-30 0.46
2017-08-31 0.48
2017-05-31 0.49
2017-02-28 0.98
2016-11-30 1.45
2016-08-31 1.40
2016-05-31 1.35
2016-02-29 0.82

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Abano Healthcare Group is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Abano Healthcare Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the New Zealand market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the New Zealand market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Abano Healthcare Group has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Abano Healthcare Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Abano Healthcare Group's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Abano Healthcare Group has delivered over 20% year on year earnings growth in the past 5 years.
  • Abano Healthcare Group's 1-year earnings growth is less than its 5-year average (0% vs 23.1%)
  • Abano Healthcare Group's earnings growth has exceeded the NZ Healthcare industry average in the past year (0% vs -4.6%).
Earnings and Revenue History
Abano Healthcare Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Abano Healthcare Group Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NZSE:ABA Past Revenue, Cash Flow and Net Income Data
Date (Data in NZD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-11-30 268.70 10.47 20.82
2018-08-31 259.45 10.38 19.92
2018-05-31 250.21 10.30 19.01
2017-11-30 224.29 10.47 16.81
2017-08-31 220.72 10.49 16.58
2017-05-31 217.14 10.51 16.34
2017-02-28 228.04 20.90 30.39
2016-11-30 222.55 30.92 29.21
2016-08-31 218.15 29.68 28.92
2016-05-31 213.74 28.44 28.63
2016-02-29 207.47 17.19 28.18
2015-11-30 201.19 5.93 27.73
2015-08-31 194.40 5.20 27.33
2015-05-31 187.60 4.47 26.93
2014-11-30 159.25 0.75 23.35
2014-08-31 165.08 0.94 23.55
2014-05-31 170.91 1.13 23.75
2014-02-28 208.14 4.25 25.48
2013-11-30 205.22 3.64 25.20
2013-08-31 206.13 3.22 24.99
2013-05-31 207.04 2.81 24.79
2013-02-28 209.64 2.67 28.25
2012-11-30 212.25 2.53 31.71
2012-08-31 209.31 2.07 28.09
2012-05-31 206.37 1.61 24.47

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Abano Healthcare Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Abano Healthcare Group used its assets less efficiently than the NZ Healthcare industry average last year based on Return on Assets.
  • Abano Healthcare Group has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Abano Healthcare Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Abano Healthcare Group has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Abano Healthcare Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Abano Healthcare Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Abano Healthcare Group's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Abano Healthcare Group's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Abano Healthcare Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Abano Healthcare Group Company Filings, last reported 4 months ago.

NZSE:ABA Past Debt and Equity Data
Date (Data in NZD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-11-30 159.89 140.36 6.49
2018-08-31 159.89 140.36 6.49
2018-05-31 158.99 100.77 3.08
2017-11-30 156.84 108.06 8.91
2017-08-31 156.84 108.06 8.91
2017-05-31 118.56 116.36 7.06
2017-02-28 118.56 116.36 7.06
2016-11-30 117.84 99.90 4.42
2016-08-31 117.84 99.90 4.42
2016-05-31 115.03 124.08 4.25
2016-02-29 115.03 124.08 4.25
2015-11-30 93.17 115.30 4.46
2015-08-31 93.17 115.30 4.46
2015-05-31 90.37 96.75 3.90
2014-11-30 96.54 96.98 5.92
2014-08-31 96.54 96.98 5.92
2014-05-31 94.86 92.07 6.30
2014-02-28 94.86 92.07 6.30
2013-11-30 93.79 86.14 5.34
2013-08-31 93.79 86.14 5.34
2013-05-31 75.34 102.62 8.55
2013-02-28 75.34 102.62 8.55
2012-11-30 74.94 100.05 13.38
2012-08-31 74.94 100.05 13.38
2012-05-31 89.98 81.84 11.09
  • Abano Healthcare Group's level of debt (87.8%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (91.9% vs 87.8% today).
  • Debt is not well covered by operating cash flow (19.3%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 5.1x coverage).
X
Financial health checks
We assess Abano Healthcare Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Abano Healthcare Group has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Abano Healthcare Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
8.93%
Current annual income from Abano Healthcare Group dividends. Estimated to be 8.71% next year.
If you bought NZ$2,000 of Abano Healthcare Group shares you are expected to receive NZ$179 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Abano Healthcare Group's pays a higher dividend yield than the bottom 25% of dividend payers in New Zealand (3.24%).
  • Abano Healthcare Group's dividend is above the markets top 25% of dividend payers in New Zealand (5.47%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NZSE:ABA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
New Zealand Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 7 Stocks 2.6%
New Zealand Market Average Dividend Yield Market Cap Weighted Average of 75 Stocks 3.8%
New Zealand Minimum Threshold Dividend Yield 10th Percentile 1.9%
New Zealand Bottom 25% Dividend Yield 25th Percentile 3.2%
New Zealand Top 25% Dividend Yield 75th Percentile 5.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NZSE:ABA Future Dividends Estimate Data
Date (Data in NZ$) Dividend per Share (annual) Avg. No. Analysts
2022-05-31 0.41 1.00
2021-05-31 0.36 2.00
2020-05-31 0.34 2.00
2019-05-31 0.32 2.00
NZSE:ABA Past Annualized Dividends Data
Date (Data in NZ$) Dividend per share (annual) Avg. Yield (%)
2018-07-24 0.360 5.368
2017-07-26 0.360 3.880
2016-12-14 0.360 4.043
2016-07-27 0.300 3.616
2015-07-29 0.250 3.268
2014-07-28 0.210 2.850
2013-07-30 0.210 3.220
2012-07-31 0.210 3.619
2011-12-20 0.210 5.009
2011-11-07 0.210 5.349
2010-12-20 0.210 4.668
2010-07-27 0.210 4.053
2009-07-28 0.210 3.668
2009-04-20 0.180 3.656

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Abano Healthcare Group's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.2x coverage).
X
Income/ dividend checks
We assess Abano Healthcare Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Abano Healthcare Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Abano Healthcare Group has a total score of 6/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Abano Healthcare Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Richard Keys
COMPENSATION NZ$666,864
TENURE AS CEO 3.4 years
CEO Bio

Mr. Richard George Keys, BCom, CA has been Chief Executive Officer of Abano Healthcare Group Limited since November 2, 2015. Mr. Keys served as the Chief Financial Officer of Abano Healthcare Group Ltd. (formerly, Eldercare New Zealand Ltd.) from 2002 to November 2, 2015 and served as its Chief Operating Officer from 2007 to November 2, 2015. Mr. Keys has a background in General Management, as well as experience in both private and public healthcare. He has worked in senior management positions within the health industry. He joined Abano in February 2002 as Business Development Manager. He serves as a Director at Bay International Ltd and Dental Partners Pty Ltd. He serves as a Director of all Abano subsidiary companies. He is a Member of the Institute of Directors. He has been a Director of New Zealand Markets Disciplinary Tribunal since July 2013. He is a Chartered Accountant and holds a Bachelor of Commerce from the University of Auckland.

CEO Compensation
  • Richard's compensation has been consistent with company performance over the past year.
  • Richard's remuneration is lower than average for companies of similar size in New Zealand.
Management Team Tenure

Average tenure of the Abano Healthcare Group management team in years:

0.8
Average Tenure
  • The average tenure for the Abano Healthcare Group management team is less than 2 years, this suggests a new team.
Management Team

Richard Keys

TITLE
Chief Executive Officer
COMPENSATION
NZ$667K
TENURE
3.4 yrs

Rosemary Ferguson

TITLE
Interim Chief Financial Officer
TENURE
0.8 yrs

Dennis Surlan

TITLE
Chief Operating Officer
TENURE
0.4 yrs

Peter Radich

TITLE
Chief Information Officer

Kerry Dunphy

TITLE
General Manager of Marketing

Andy Tapper

TITLE
Chief Strategy & Business Development Officer

Karen Wood

TITLE
Chief Executive Officer of Aotea Pathology

David Rogers

TITLE
Chief Executive Officer of Insight+Ascot Radiology

Con Balasoglou

TITLE
Chief Executive Officer of Orthotics Centre

Robin Cooper

TITLE
Chief Executive Officer of Abano Rehabilitation
Board of Directors Tenure

Average tenure of the Abano Healthcare Group board of directors in years:

3.4
Average Tenure
  • The tenure for the Abano Healthcare Group board of directors is about average.
Board of Directors

Trevor Janes

TITLE
Independent Chairman
COMPENSATION
NZ$157K
AGE
73
TENURE
7.4 yrs

Pip Dunphy

TITLE
Deputy Chairman
COMPENSATION
NZ$133K
TENURE
3.4 yrs

Danny Chan

TITLE
Independent Director
COMPENSATION
NZ$70K
TENURE
10.3 yrs

Murray Boyte

TITLE
Independent Director
COMPENSATION
NZ$66K
TENURE
4.2 yrs

Ginni Mansberg

TITLE
Independent Director
COMPENSATION
NZ$53K
TENURE
2.7 yrs

Tracy Batten

TITLE
Independent Director
TENURE
0.9 yrs

Mike Allen

TITLE
Independent Director
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (NZ$) Value (NZ$)
X
Management checks
We assess Abano Healthcare Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Abano Healthcare Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

A Look At The Intrinsic Value Of Abano Healthcare Group Limited (NZSE:ABA)

I will be using the Discounted Cash Flow (DCF) model. … If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. … We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows

Simply Wall St -

Is It Too Late To Buy Abano Healthcare Group Limited (NZSE:ABA) At Its April Price?

Abano Healthcare Group Limited (NZSE:ABA) is considered a high-growth stock, but its last closing price of NZ$3.96 left some investors wondering if this high future earnings potential can be rationalized by its current price tag. … Let’s take a look at some key metrics to determine whether there's any value here for current and potential future investors. … Investors in Abano Healthcare Group have been patiently waiting for the uptick in earnings.

Simply Wall St -

Dividend Hunters Should Consider Abano Healthcare Group Limited (NZSE:ABA), With A 8.2% Yield

If you are an income investor, then Abano Healthcare Group Limited (NZSE:ABA) should be on your radar. … Abano Healthcare Group Limited provides healthcare and medical services. … Currently yielding 8.2%, let's take a closer look at Abano Healthcare Group's dividend profile.

Simply Wall St -

Should You Be Concerned About Abano Healthcare Group Limited's (NZSE:ABA) Earnings Growth?

Understanding Abano Healthcare Group Limited's (NZSE:ABA) performance as a company requires examining more than earnings from one point in time. … Today I will take you through a basic sense check to gain perspective on how Abano Healthcare Group is doing by evaluating its latest earnings with its longer term trend as well as its industry peers' performance over the same period. … View our latest analysis for Abano Healthcare Group.

Simply Wall St -

Could The Abano Healthcare Group Limited (NZSE:ABA) Ownership Structure Tell Us Something Useful?

If you want to know who really controls Abano Healthcare Group Limited (NZSE:ABA), then you'll have to look at the makeup of its share registry. … With a market capitalization of NZ$162m, Abano Healthcare Group is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for Abano Healthcare Group

Simply Wall St -

What You Must Know About Abano Healthcare Group Limited's (NZSE:ABA) Financial Strength

While small-cap stocks, such as Abano Healthcare Group Limited (NZSE:ABA) with its market cap of NZ$158m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … Healthcare companies,.

Simply Wall St -

Should You Be Concerned About Abano Healthcare Group Limited's (NZSE:ABA) ROE?

To keep the lesson grounded in practicality, we'll use ROE to better understand Abano Healthcare Group Limited (NZSE:ABA). … That means that for every NZ$1 worth of shareholders' equity, it generated NZ$0.066 in profit. … Check out our latest analysis for Abano Healthcare Group?

Simply Wall St -

Is Abano Healthcare Group Limited’s (NZSE:ABA) 8.1% ROCE Any Good?

Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. … Return On Capital Employed (ROCE): What is it? … ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business.

Simply Wall St -

How Much is Abano Healthcare Group Limited's (NZSE:ABA) CEO Getting Paid?

Richard Keys became the CEO of Abano Healthcare Group Limited (NZSE:ABA) in 2015. … This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Richard Keys's Compensation Compare With Similar Sized Companies?

Simply Wall St -

Abano Healthcare Group Limited (NZSE:ABA): What’s In It For The Shareholders?

Today we will examine Abano Healthcare Group’s ability to generate cash flows, as well as the level of capital expenditure it is expected to incur over the next couple of years, which will result in how much money goes to you. … Abano Healthcare Group generates cash through its day-to-day business, which needs to be reinvested into the company in order for it to continue operating. … There are two methods I will use to evaluate the quality of Abano Healthcare Group’s FCF: firstly, I will measure its FCF yield relative to the market index yield; secondly, I will examine whether its operating cash flow will continue to grow into the future, which will give us a sense of sustainability

Simply Wall St -

Company Info

Description

Abano Healthcare Group Limited provides healthcare and medical services. It operates through Dental and Diagnostics segments. The company offers a range of general and specialist dental works, including restorative and cosmetic dental services; and scanning services, including MRI, CT, PET CT, and ultrasound scanning, as well as mammography and interventional radiology services. As of May 31, 2018, it operated approximately 225 dental practices in New Zealand and Australia. The company was formerly known as ElderCare New Zealand Limited and changed its name to Abano Healthcare Group Limited in August 2003. Abano Healthcare Group Limited was incorporated in 1961 and is based in Auckland, New Zealand.

Details
Name: Abano Healthcare Group Limited
ABA
Exchange: NZSE
Founded: 1961
NZ$105,872,981
26,141,477
Website: http://www.abano.co.nz
Address: Abano Healthcare Group Limited
West Plaza Building,
16 Floor,
Auckland,
New Zealand
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NZSE ABA Ordinary Shares New Zealand Stock Exchange NZ NZD 02. Jan 1992
Number of employees
Current staff
Staff numbers
0
Abano Healthcare Group employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/18 10:32
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/03/27
Last earnings filing: 2018/12/20
Last earnings reported: 2018/11/30
Last annual earnings reported: 2018/05/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.